Level Chart

Basic Info

Becton Dickinson and Co (BDX) - Biosciences Revenue is at a current level of 387.00M, up from 358.00M last quarter and down from 397.00M one year ago. This is a change of 8.10% from last quarter and -2.52% from one year ago.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 387.00M
Latest Period Sep 2025
Last Updated Dec 18 2025, 15:07 EST
Next Release Jan 30 2026, 08:30 EST (E)
Average Growth Rate 4.75%
Value from Last Quarter 358.00M
Change from Last Quarter 8.10%
Value from 1 Year Ago 397.00M
Change from 1 Year Ago -2.52%
Frequency Quarterly
Unit USD
Adjustment N/A
Download Source File Upgrade

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
September 30, 2025 387.00M
June 30, 2025 358.00M
March 31, 2025 352.00M
December 31, 2024 361.00M
September 30, 2024 397.00M
June 30, 2024 363.00M
March 31, 2024 377.00M
December 31, 2023 375.00M
September 30, 2023 405.00M
June 30, 2023 368.00M
March 31, 2023 386.00M
December 31, 2022 349.00M
Date Value
September 30, 2022 358.00M
June 30, 2022 348.00M
March 31, 2022 335.00M
December 31, 2021 338.00M
September 30, 2021 352.00M
June 30, 2021 316.00M
March 31, 2021 325.00M
December 31, 2020 312.00M
September 30, 2020 303.00M
June 30, 2020 237.00M
March 31, 2020 280.00M
December 31, 2019 323.00M

Basic Info

Becton Dickinson and Co (BDX) - Biosciences Revenue is at a current level of 387.00M, up from 358.00M last quarter and down from 397.00M one year ago. This is a change of 8.10% from last quarter and -2.52% from one year ago.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 387.00M
Latest Period Sep 2025
Last Updated Dec 18 2025, 15:07 EST
Next Release Jan 30 2026, 08:30 EST (E)
Average Growth Rate 4.75%
Value from Last Quarter 358.00M
Change from Last Quarter 8.10%
Value from 1 Year Ago 397.00M
Change from 1 Year Ago -2.52%
Frequency Quarterly
Unit USD
Adjustment N/A
Download Source File Upgrade

Related Securities

Symbol Name Change %
BDX Becton, Dickinson & Co. -0.79%